Home ยป Klk10 overexpression in KRAS mutant colorectal cancer promotes disease progression and drug resistance via the PAR1-PDK1-AKT signaling pathway
Pubmed Latest

Klk10 overexpression in KRAS mutant colorectal cancer promotes disease progression and drug resistance via the PAR1-PDK1-AKT signaling pathway

by satcit
written by satcit

https://pubmed.ncbi.nlm.nih.gov/38115179

KLK10’s overexpression in KRAS mutant colorectal cancer promotes disease progression and drug resistance via the PAR1-PDK1-AKT signaling pathway.

You may also like

“Addressing Modifiable Risk Factors to Improve Cardiovascular Outcomes:...

“Modifiable Risk Factors’ Impact on Cardiovascular Outcomes: A...

“Semaglutide May Improve Heart Failure in Obese Patients...

Semaglutide’s Potential Beneficial Effects on Heart Failure with...

“Semaglutide May Lower Heart Failure Hospitalization Risk in...

“Semaglutide May Reduce Cardiovascular Risks in Heart Failure...

“Methemoglobinemia Outbreak in Japanese Neonatal ICU and Maternity...

“New Perspectives on Medical Ethics: A Commentary in...

“Balancing Probability and Precision in Designing Future ARDS...

“Evaluating Doxycycline Postexposure Prophylaxis for Preventing Sexually Transmitted...

Leave a Comment

Save my name, email, and website in this browser for the next time I comment.

@2023 - All Right Reserved.